¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Phosphofructokinase-1, Muscle Type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • muscle tone
    ±Ù(À°)±äÀåµµ
  • muscle transposition
    ±Ù(À°)ÀÚ¸®¿Å±è(¼ú), ±Ù(À°)ÀüÀ§(¼ú)
  • muscle-paretic nystagmus
    ±Ù(À°)¸¶ºñ´«¶³¸², ±Ù¸¶ºñ¾ÈÁø
  • mylohyoid muscle
    Åθñ»Ô±Ù, ÇϾǼ³°ñ±Ù
  • masseter muscle
    ±ú¹°±Ù, ±³±Ù
  • masticatory muscle
    ¾Ã±â±ÙÀ°, ÀúÀÛ±Ù
  • nonstriated muscle
    ¹Î¹«´Ì±ÙÀ°, ÆòȰ±Ù
  • nasalis muscle
    ÄÚ±Ù, ºñ±Ù
  • ocular muscle
    ¾È±¸±ÙÀ°, ¾È±Ù
  • oblique arytenoid muscle
    ºø¸ð»Ô±Ù, °æ»çÇÇ¿­±Ù
  • oblique muscle
    ºø±Ù, °æ»ç±Ù
  • omohyoid muscle
    ¾î±ú¸ñ»Ô±Ù, °ß°©¼³°ñ±Ù
  • opponens pollicis muscle
    ¾öÁö¸Â¼¶±Ù, ¹«Áö´ë¸³±Ù
  • orbicular muscle
    µÑ·¹±Ù, À±±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • intercostal muscle
    °¥ºñ»çÀ̱Ù
  • internal oblique abdominal muscle
    ¹è¼Óºø±Ù
  • interosseous muscle
    »À»çÀ̱Ù
  • involuntary muscle
    ºÒ¼öÀDZÙ
  • ischiocavernous muscle
    ±ÃµÕÇØ¸éü±Ù, Á°ñÇØ¸éü±Ù
  • muscle splitting incision
    ±ÙÀ°°¡¸£±âÀý°³
  • latissimus dorsi muscle
    ³ÐÀºµî±Ù
  • levator muscle
    ¿Ã¸²±Ù
  • levator anguli oris muscle
    ÀÔ²¿¸®¿Ã¸²±Ù
  • levator ani muscle
    Ç×¹®¿Ã¸²±Ù
  • levator labii superioris muscle
    À§ÀÔ¼ú¿Ã¸²±Ù
  • levator labii superioris alaque nasi muscle
    À§ÀÔ¼úÄà¹æ¿ï¿Ã¸²±Ù
  • levator palpebrae muscle
    ´«²¨Ç®¿Ã¸²±Ù
  • levator veli palatini muscle
    ÀÔõÀå¿Ã¸²±Ù
  • longissimus muscle
    °¡Àå±ä±Ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • iliococcygeal muscle ³ª musculus 1iliococcygeus
    Àå°ñ¹Ì°ñ±Ù.
  • iliococcygeal muscle ³ª musculus 1iliococcygeus
    Àå°ñ ¹Ì°ñ±Ù.
  • iliocostal muscle of loin ; musculus iliocostalis lumborum
    Ç㸮Àå°ñ´Á°ñ±Ù, ¿äÀå´Á±Ù.
  • iliocostal muscle of neck ; musculus iliocostalis cervicis
    ¸ñÀå°ñ´Á°ñ°ï, °æÀå´Á±Ù.
  • iliocostal muscle of thorax ; musculus iliocostalis thoracis
    µîÀå°ñ´Á°ñ±Ù, ÈäÀå´Á±Ù(ýØíó×ÎÐÉ).
  • iliocostal muscle ³ª musclus iliocostalis
    Àå°ñ´Á°ñ±Ù, Àå´Á±Ù(íó×ÎÐÉ).
  • iliopsoas muscle
    Àå¿ä±Ù
  • iliopsoas muscle <³ª> musculus i.
    Àå¿ä±Ù(Àå¿ä±Ù).
  • iliopsoas muscle ³ª musculus i.
    Àå°ñÇ㸮±Ù, Àå¿ä±Ù(íóé¦ÐÉ).
  • inferior lingual muscle
    Çϼ³±Ù
  • inferior pharyngeal constrictor muscle
    ÇÏÀεμöÃà±Ù
  • inferior pharyngeal constrictor muscle
    ¾Æ·¡ÀεμöÃà±Ù
  • inferior rectus muscle
    ¾Æ·¡°ðÀº¼±, ÇÏÁ÷±Ù(ù»òÁÐÉ).
  • inferior rectus muscle
    ¾Æ·¡°ðÀº±Ù
  • inferior rectus muscle
    ÇÏÁ÷±Ù, ¾Æ·¡°ðÀº±Ù{ÇØ}
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • herpes simplex virus type 1
    Á¦1Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
  • herpes simplex virus type 2
    Á¦2Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
  • htlv,type i
    type 1Çü
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • hutchinson-type neuroblastoma
    ÇãÄ£½¼(Hutchinson)Çü ½Å°æ¸ð¼¼Æ÷Á¾
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperlipoproteinemia type IV
    °í´Ü¹éÇ÷Áõ IV Çü
  • hyperlipoprotenemia type II
    °íÁö´Ü¹éÇ÷Áõ II Çü
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
CRPS complex regional pain syndrome [type I and II]
CSB contaminated small bowel; craniosynostosis, Boston type
DAT delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to...
DS-DAT Discomfort Scale for Dementia of the Alzheimer Type
DTD diastrophic dysplasia; document type definition
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
MPLM Myenteric plexus-longitudinal muscle
PMR Progressive Muscle Relaxation
PASMC Pulmonary artery smooth muscle cell
RASMC Rat aortic smooth muscle cells
RM Respiratory muscle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lateral great muscle
    ¿ÜÃø ±¤±Ù
  • lateral pterygoid muscle
    ¿ÜÀ͵¹±Ù, ¿ÜÃøÀͰñ±Ù
    1. 2°³·Î ³ª´©¾îÁö¸ç, ¿ÜÀ͵¹ ÆÇ°ú Á¢Çü°ñÀÇ ´ëÀÍ
  • levarterenol bitartrate : ³ë¸£¿¡Çdz×ÇǸ°ÀÇ Á¼±¼º À̼ºÁúü.

    levater labii superioris muscle

    »ó¼ø°Å±Ù
    ¾È¿Í Çϰø ¹Ù·Î À§¿¡¼­ ±â½ÃÇϰí, ¾Æ·¡·Î ³»·Á°¡¼­ À­ ÀÔ¼úÀÇ ¿ÜÃø Àý¹Ý ºÎÀ§ÀÇ ÇǺο¡ Á¤ÁöÇÑ´Ù.
  • levator muscle of scapula. »óÃø 4 °æÃßÀÇ È¾µ¹±â¿¡¼­ ±â½ÃÇÏ¿© °ß°©°ñÀÇ ³»Ãø¿¬¿¡¼­ Á¤ÁöÇÑ´Ù. Á¦ 3, 4 ½Å°æÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, °ß°©°ñÀ» °Å»óÇÑ´Ù.

    levator palpebrae superioris

    »ó¾È°Ë°Å±Ù
    ½Ã½Å°æ°üÀÇ »ó¿¬¿¡¼­ ±â½ÃÇÏ¿© »ó¾È°ËÀÇ ¾È°ËÆÇ¿¡¼­ Á¤ÁöÇÑ´Ù. µ¿¾È ½Å°æÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, »ó¼øÀ» °Å»óÇÑ´Ù.
  • levator veli palatini muscle
    ±¸°³°Å±Ù
  • ligamentous muscle sprain
    Àδ뼺 ±Ù ¿°ÁÂ
  • local muscle sensitivity
    ±¹¼ÒÀû ±Ù°ú¹Î¼º
  • longitudinalis inferior muscle
    ÇÏÁ¾¼³±Ù
  • longitudinalis superior muscle
    »óÁ¾¼³±Ù
  • masseter muscle
    ±³±Ù
    1. Ç¥Ãþ ±³±ÙÀº Çù°ñ µ¹±â¿Í Çù°ñ ±Ã¿¡¼­ ±â½ÃÇÏ¿© ÇÏ¾Ç Áö¿Í ÇÏ¾Ç °¢ ºÎÀ§¿¡ ºÎÂøÇϸç, ½ÉºÎ ±³±ÙÀº Ç÷°ñ ±Ã¿¡¼­ ±â½ÃÇÏ¿© ÇÏ¾Ç Áö »ó¹æ 1/2°ú ÇϾÇÀÇ ¿ÀÈÑ µ¹±â¿¡ ºÎÂøÇÑ´Ù. ÇϾÇÀ» °Å»ó½ÃŰ´Â °­·ÂÇÑ ÀúÀÛ±ÙÀÌ´Ù. 2. ÇϾÇÁö ¿Ü¸é¿¡ ºÎÂøµÈ À广ÇüÀÇ ±ÙÀ̰í, ÇÏ¾Ç ½Å°æÀÇ ±³±Ù ½Å°æÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, ±³ÇÕ·Â ¹ß»ý°ú Æó±¸¿¡ °ü°èÇϰí, Ç¥ÃþºÎ´Â ÇϾÇÀÇ ÀüÁø ¿îµ¿¿¡, ½ÉÃþºÎ´Â ÇϾÇÀÇ ÈÄÅð ¿îµ¿¿¡ °ü¿©ÇÑ´Ù. 3. ÀúÀÛ±ÙÀÇ Çϳª. ÅÎÀÇ Ãø¸é¿¡ Àִµ¥ ±¤´ë »À¿¡¼­ ½ÃÀÛµÇ¾î ¾Æ·¡ ÅÎ »À·Î À̾îÁö¹Ç·Î ¾Æ·¡ ÅÎÀ» ²ø¾î¿Ã·Á À§ ÅÎÀ¸·Î ¹Ð¾îºÙÀÌ´Â ÀÛ¿ëÀ» ÇÑ´Ù. À½½Ä¹°À» ¾ÃÀ» ¶§ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. ÇǺΠ¹Ù·Î ¹Ø¿¡ ÀÖÀ¸¹Ç·Î ¾Æ·¡À§ÀÇ ÅÎÀ» ²À ¹°¸é ±ÍÀÇ ¾ÕÂÊ ¾Æ·§ ºÎºÐ¿¡¼­ ½ÉÁÙÀÇ ¿îµ¿À» ¸¸Á®º¼ ¼ö°¡ ÀÖ´Ù. »ïÂ÷ ½Å°æÀÇ Á¦3ÁöÀÎ ¾Æ·¡ ÅÎ ½Å°æ¿¡ ÀÇÇÏ¿© Áö¹èµÈ´Ù.
  • masticatory muscle
    ÀúÀÛ±Ù
    ÇÑ ½ÖÀÇ ±³±Ù, ÃøµÎ±Ù, ¿ÜÀ͵¹±Ù, ±×¸®°í ³»À͵¹±ÙÀ» Æ÷ÇÔÇÏ´Â, ÀúÀÛ ¿îµ¿¿¡ ÇÊ¿äÇÑ ±ÙÀ°µé.
  • masticatory muscle dyskinesia
    ÀúÀÛ±Ù ºÎÁ¶È­, ÀúÀÛ±Ù ÀÌ»ó ¿îµ¿Áõ
  • masticatory muscle pain disorder
    ÀúÀÛ±Ù µ¿Åë Àå¾Ö
  • masticatory muscle silent
    ÀúÀÛ±ÙÀÇ ÈÞÁö±â
  • motor nerve fiber of skeletal muscle
    °ñ°Ý±ÙÀÇ ¿îµ¿ ½Å°æ ´º·±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
type I diabetes A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes.
(09 Oct 1997)
type I diabetes mellitus <endocrinology> A severe metabolic disorder which has an abrupt onset before the age of twenty. In it, an insulin deficiency prevents the body from using carbohydrates properly and forces it to rely mainly on protein metabolism.
Treatment of the disease includes strict dietary regulation and mandatory insulin injections.
(09 Oct 1997)
type I dip Early deceleration of the foetal heart rate at the height of uterine contraction, as displayed on a foetal monitor graph.
(05 Mar 2000)
type i error The statistical error (said to be of the first kind or alpha error) made in testing an hypothesis when it is concluded that a treatment or intervention is effective when it really is not. Sometimes referred to as a false positive.
(12 Dec 1998)
type I familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by the presence of large amounts of chylomicrons and triglycerides in the plasma when the patient has a normal diet, and their disappearance on a fat-free diet; low alpha-and beta-lipoproteins on a normal diet, with increase on fat-free diet; decreased plasma postheparin lipolytic activity; and low tissue lipoprotein lipase activity. It is accompanied by bouts of abdominal pain, hepatosplenomegaly, pancreatitis, and eruptive xanthomas; autosomal recessive inheritance.
See: familial lipoprotein lipase inhibitor.
Synonym: Burger-Grutz syndrome, familial fat-induced hyperlipaemia, familial hyperchylomicronaemia, familial hypertriglyceridemia, idiopathic hyperlipaemia.
(05 Mar 2000)
type IH mucopolysaccharidosis <syndrome> Mucopolysaccharidosis in which there is a deficiency of alpha-l-iduronidase, an accumulation of an abnormal intracellular material, and excretion of dermatan sulfate and heparan sulfate in the urine; with severe abnormality in development of skeletal cartilage and bone, with dwarfism, kyphosis, deformed limbs, limitation of joint motion, spadelike hand, corneal clouding, hepatosplenomegaly, mental retardation, and gargoyle-like facies; autosomal recessive inheritance.
See: mucolipidosis.
Synonym: dysostosis multiplex, Hurler's disease, lipochondrodystrophy, Pfaundler-Hurler syndrome, type IH mucopolysaccharidosis.
(05 Mar 2000)
type I H/S mucopolysaccharidosis <syndrome> Although clinically distinct diseases, fibroblasts from patients with Hurler syndrome and with Scheie syndrome do not cross complement in culture, suggesting that the enzyme defect is the same.
(18 Nov 1997)
type I hyperlipoproteinaemia <biochemistry> An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood.
Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas).
Origin: Gr. Haima = blood
(27 Sep 1997)
type II acrocephalosyndactyly type II acrocephalosyndactyly
type II cells Cuboidal cell's connected with the squamous pulmonary alveolar cell's and having in their cytoplasm lamellated bodies (cytosomes) that represent the source of the surfactant that coats the alveoli.
Synonym: granular pneumonocytes, type II cells.
(05 Mar 2000)
type II collagen Collagen unique to cartilage, nucleus pulposis, notochord, and vitreous body; it forms as thin highly glycosylated fibrils.
(05 Mar 2000)
type II diabetes <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop.
(05 Mar 2000)
type II dip Late deceleration of the foetal heart rate, 30 seconds or more after the height of uterine contraction, as displayed on a foetal monitor graph.
(05 Mar 2000)
type II error The statistical error (said to be of the second kind or beta error) made in testing an hypothesis when it is concluded that a treatment or intervention is not effective when it really is. Sometimes referred to as a false negative.
(12 Dec 1998)
type II familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by increased plasma levels of beta-lipoproteins, cholesterol, and phospholipids, but normal triglycerides; heterozygotes have mild lipid changes and are susceptible to atherosclerosis in middle age, but homozygotes have severe changes often with generalised xanthomatosis and xanthelasma, and frank clinical atherosclerosis as young adults. The primary defect is a deficiency of apoprotein of VLDL, and the disorder is divided into two classes: 1) type IIA, which has elevated LDL due to a deficiency of the receptor or a modified apolipoprotein B-100; 2) type IIB, which has elevated LDL and triglycerides; autosomal dominant inheritance.
Synonym: familial hyperbetalipoproteinaemia, familial hypercholesteraemic xanthomatosis, familial hypercholesterolaemia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á